Cleveland BioLabs
CBLI
#9906
Rank
NZ$86.17 M
Marketcap
NZ$5.57
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Earnings for Cleveland BioLabs (CBLI)

Earnings in 2021 (TTM): -NZ$3.97 Million

According to Cleveland BioLabs 's latest financial reports the company's current earnings are NZ$0.63 Million. In 2020 the company made an earning of -NZ$4.52 Million a decrease over its 2019 earnings that were of -NZ$4.15 Million.

Earnings history for Cleveland BioLabs from 2004 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-NZ$3.97 Million-12.15%
2020-NZ$4.52 Million8.8%
2019-NZ$4.15 Million-50.81%
2018-NZ$8.43 Million-14.3%
2017-NZ$9.84 Million-11.88%
2016-NZ$11.17 Million-50.9%
2015-NZ$22.74 Million-10.24%
2014-NZ$25.33 Million-37.5%
2013-NZ$40.53 Million-23.2%
2012-NZ$52.77 Million19.68%
2011-NZ$44.09 Million133.81%
2010-NZ$18.86 Million68.22%
2009-NZ$11.21 Million-55.51%
2008-NZ$25.2 Million-45.62%
2007-NZ$46.34 Million255.63%
2006-NZ$13.03 Million198.18%
2005-NZ$4.37 Million-1.25%
2004-NZ$4.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$28.71 B-594,165.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
NZ$45.18 B-934,906.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.76 B-326,196.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$13.52 B-279,814.16%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$16.38 B-338,984.53%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$17.37 B-359,611.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-NZ$21.73 Million 349.36%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-NZ$0.29 Billion 5,693.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$31.89 Million 559.60%๐Ÿ‡บ๐Ÿ‡ธ USA